Aflac Incorporated (NYSE:AFL) Shares Sold by Tradition Wealth Management LLC

Tradition Wealth Management LLC decreased its holdings in Aflac Incorporated (NYSE:AFLFree Report) by 8.5% in the 4th quarter, Holdings Channel reports. The institutional investor owned 2,884 shares of the financial services provider’s stock after selling 268 shares during the period. Tradition Wealth Management LLC’s holdings in Aflac were worth $298,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently modified their holdings of the stock. Norges Bank purchased a new stake in Aflac in the fourth quarter valued at approximately $349,699,000. Raymond James Financial Inc. acquired a new stake in shares of Aflac during the 4th quarter worth $163,409,000. Amundi raised its position in shares of Aflac by 81.1% in the 4th quarter. Amundi now owns 2,753,513 shares of the financial services provider’s stock worth $285,181,000 after buying an additional 1,232,683 shares during the period. Vanguard Group Inc. grew its position in Aflac by 1.3% during the fourth quarter. Vanguard Group Inc. now owns 51,340,298 shares of the financial services provider’s stock valued at $5,310,640,000 after acquiring an additional 653,275 shares during the period. Finally, Assenagon Asset Management S.A. increased its stake in Aflac by 670.9% during the fourth quarter. Assenagon Asset Management S.A. now owns 556,576 shares of the financial services provider’s stock worth $57,572,000 after acquiring an additional 484,378 shares during the last quarter. Institutional investors and hedge funds own 67.44% of the company’s stock.

Wall Street Analyst Weigh In

A number of brokerages have recently issued reports on AFL. Morgan Stanley decreased their target price on Aflac from $105.00 to $100.00 and set an “equal weight” rating for the company in a report on Thursday, April 10th. Keefe, Bruyette & Woods reduced their target price on shares of Aflac from $107.00 to $104.00 and set a “market perform” rating on the stock in a report on Wednesday, February 12th. UBS Group increased their price target on Aflac from $109.00 to $114.00 and gave the company a “neutral” rating in a report on Wednesday, April 2nd. Piper Sandler upped their target price on Aflac from $118.00 to $124.00 and gave the stock an “overweight” rating in a research report on Wednesday, April 2nd. Finally, StockNews.com upgraded Aflac from a “sell” rating to a “hold” rating in a report on Friday, February 14th. Two research analysts have rated the stock with a sell rating, eleven have issued a hold rating and two have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, Aflac has a consensus rating of “Hold” and an average target price of $103.93.

Read Our Latest Research Report on Aflac

Aflac Stock Down 2.3 %

Shares of Aflac stock opened at $104.99 on Tuesday. The company has a quick ratio of 0.08, a current ratio of 0.10 and a debt-to-equity ratio of 0.29. The business has a 50-day moving average price of $106.76 and a 200 day moving average price of $107.16. Aflac Incorporated has a fifty-two week low of $80.59 and a fifty-two week high of $115.50. The firm has a market cap of $57.31 billion, a P/E ratio of 10.94, a P/E/G ratio of 3.24 and a beta of 0.81.

Aflac (NYSE:AFLGet Free Report) last released its quarterly earnings data on Wednesday, February 5th. The financial services provider reported $1.56 EPS for the quarter, missing analysts’ consensus estimates of $1.63 by ($0.07). Aflac had a return on equity of 16.20% and a net margin of 28.76%. On average, sell-side analysts forecast that Aflac Incorporated will post 6.88 earnings per share for the current fiscal year.

Insider Buying and Selling

In related news, Director Charles D. Lake II sold 29,802 shares of the business’s stock in a transaction that occurred on Monday, March 10th. The stock was sold at an average price of $107.29, for a total transaction of $3,197,456.58. Following the completion of the transaction, the director now owns 49,962 shares in the company, valued at $5,360,422.98. The trade was a 37.36 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Joseph L. Moskowitz sold 1,000 shares of the stock in a transaction on Friday, March 7th. The stock was sold at an average price of $107.63, for a total value of $107,630.00. Following the completion of the sale, the director now directly owns 25,393 shares in the company, valued at $2,733,048.59. This represents a 3.79 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 0.90% of the stock is owned by company insiders.

About Aflac

(Free Report)

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.

Featured Stories

Want to see what other hedge funds are holding AFL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aflac Incorporated (NYSE:AFLFree Report).

Institutional Ownership by Quarter for Aflac (NYSE:AFL)

Receive News & Ratings for Aflac Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aflac and related companies with MarketBeat.com's FREE daily email newsletter.